NEW YORK, July 7, 2026 -(BUSINESS WIRE)- VB Spine LLC (“VB Spine”) today announced it has entered into a definitive agreement to acquire the exclusive rights to Augmedics’ CT-to-fluoroscopy (CT-Fluoro) technology for spine applications.
VB Spine to Acquire CT-Fluoro Technology for Spine Applications from Augmedics
2 min read Premium comments
agreementVB Spine LLCAugmedics’ CT-to-fluoroscopy (CT-Fluoro)spine applicationsacquire exclusive rights
This acquisition reflects VB Spine’s ongoing investment in innovative technologies, building on the acquisition of exclusive rights to the Augmedics’ xvision Spine System® platform in April. With CT-Fluoro technology, surgeons are able to register a patient’s preoperative CT scan using standard fluoroscopic imaging, potentially eliminating the need for intraoperative CT or 3D imaging systems during spine procedures. By expanding workflow flexibility and reducing imaging requirements, CT-Fluoro technology helps make augmented reality navigation more accessible across a broader range of facilities and surgical settings.
“At VB Spine, our goal is to remove barriers that prevent surgeons from accessing technologies that improve procedural efficiency and patient care,” said Marc Viscogliosi, co-CEO of VB Spine, speaking on behalf of his brothers and fellow co-CEOs Anthony and John Viscogliosi. “The addition of CT-Fluoro technology for spine applications will be an important step forward for the xvision platform because it provides surgeons with greater flexibility in how they utilize navigation.”
The addition of CT-Fluoro technology further strengthens the xvision ecosystem and underscores VB Spine’s long-term commitment to investing in enabling technologies that simplify adoption, expand access, and keep patient outcomes at the center of innovation.
Following the closing of the transaction, VB Spine intends to make CT-Fluoro technology available as part of its technology offerings for spine procedures. The transaction is subject to customary closing conditions and regulatory requirements. Terms of the transaction were not disclosed.
Forward-looking statements
Certain statements in this release are forward-looking and are based on current expectations, forecasts, and assumptions. Actual results may differ materially due to regulatory, commercial, and operational risks. VB Spine disclaims any obligation to update forward-looking statements except as required by law.
About VB Spine
VB Spine LLC is the largest privately held spine company and among the largest family-owned medical technology companies in the world. With a comprehensive portfolio and a large and growing global distribution network, VB Spine delivers specialized solutions that address critical needs in spine surgery and enhance patient outcomes. Focused on people, partnerships, and operational excellence, VB Spine ensures healthcare professionals have access to the tools and resources needed to provide the highest standard of care. VB Spine is owned and led by the Viscogliosi Brothers. For more information on VB Spine, please visit www.vbspineco.com.
Contacts
For media inquiries only:
spinecommunications@vbspineco.com
Why This Matters
Two Perspectives
MBA Lens: Economic and industry impact
VB Spine's acquisition of exclusive rights to Augmedics’ CT-Fluoro technology for spine applications strategically enhances its xvision platform. This move aims to broaden market access for augmented reality navigation by simplifying workflow and potentially reducing capital equipment needs. By enabling preoperative CT registration with standard fluoroscopy, VB Spine seeks to remove adoption barriers, improve procedural efficiency, and strengthen its competitive position in the spine technology market.
- The acquisition expands the accessibility of augmented reality navigation to a wider range of facilities and surgical settings.
- It potentially reduces imaging requirements and associated costs by eliminating the need for intraoperative CT or 3D imaging systems.
PhD Lens: Clinical and outcomes impact
VB Spine has acquired CT-Fluoro technology, which enables surgeons to register a patient’s preoperative CT scan using standard fluoroscopic imaging for spine applications. This technology integrates with the xvision Spine System®, potentially eliminating the need for intraoperative CT or 3D imaging during procedures. The mechanism aims to provide augmented reality navigation guidance by correlating pre-existing high-resolution anatomical data with real-time fluoroscopic views.
- The technology registers preoperative CT data using standard fluoroscopic images, streamlining intraoperative imaging protocols.
- It is designed to enhance the xvision platform by offering greater flexibility in utilizing navigation without additional intraoperative 3D scans.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.